Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP2 | P08253 | 8/20 | 0.39 |
| ▸ | MMP8 | P22894 | 5/20 | 0.39 |
| ▸ | MMP3 | P08254 | 5/20 | 0.39 |
| ▸ | CA2 | P00918 | 3/20 | 0.39 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.36 |
| ▸ | MMP1 | P03956 | 5/20 | 0.33 |
| ▸ | MMP9 | P14780 | 4/20 | 0.33 |
| ▸ | BLM | P54132 | 2/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA9 | Q16790 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL7452703 | 0.95 | MMP2 (0.37) | MMP2MMP8MMP3CA2SLC34A1 | |
| Ammonia Solution, Strong SCHEMBL11583952 | 0.95 | MMP2 (0.37) | MMP2MMP8MMP3CA2SLC34A1 | |
| Ammonia Solution, Strong SCHEMBL11583945 | 0.95 | MMP2 (0.37) | MMP2MMP8MMP3CA2SLC34A1 | |
| SCHEMBL11623912 | 0.95 | MMP2 (0.37) | MMP2MMP8MMP3CA2SLC34A1 | |
| Water SCHEMBL7452695 | 0.95 | MMP2 (0.37) | MMP2MMP8MMP3CA2SLC34A1 | |
| SCHEMBL16383139 | 0.76 | CA2 (0.47) | MMP2MMP8MMP3CA2MMP1 | |
| SCHEMBL11054896 | 0.72 | — | — | |
| SCHEMBL31707295 | 0.72 | — | — | |
| Foscarnet SCHEMBL23633 | 0.70 | — | — | |
| Foscarnet SCHEMBL8647698 | 0.70 | BLM (0.41) | MMP2MMP8MMP3CA2SLC34A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 432 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4731786-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTENSION | Pacific Biosciences of California, Inc. (US) | 2026-04-29 | — | — | EP | claimed |
| EP-4705500-A2 | REAGENT USED IN DEPROTECTION OF 3'-O-AMINO POLYNUCLEOTIDES | DNA Script (FR) | 2026-03-11 | — | — | EP | claimed |
| WO-2025006432-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTENSION | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-01-02 | — | — | WO | claimed |
| US-20250002960-A1 | COMPOSITIONS AND METHODS FOR NUCLEIC ACID EXTENSION | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (US) | 2025-01-02 | — | — | US | claimed |
| WO-2024227846-A2 | REAGENT USED IN DEPROTECTION OF 3'-O-AMINO POLYNUCLEOTIDES | DNA SCRIPT (FR) | 2024-11-07 | — | — | WO | claimed |
| WO-2018158297-A1 | CHK1 INHIBITION, SYNTHETIC LETHALITY AND CANCER TREATMENT | THE INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL (GB) | 2018-09-07 | — | — | WO | claimed |
| CN-106496268-A | Phosphonyl-substituted methanol derivative and preparation method and application thereof | 苏州大学 | 2017-03-15 | — | — | CN | claimed |
| US-20040236135-A1 | Preparation and use of alpha-keto phosphonates | SOUTHERN CALIFORNIA, UNIVERSITY OF | 2004-11-25 | — | — | US | claimed |
| WO-2003011221-A2 | PREPARATION AND USE OF α-KETO PHOSPHONATES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2003-02-13 | — | — | WO | claimed |
| EP-1097160-A4 | PREPARATION AND USE OF ALPHA-KETO BISPHOSPHONATES | UNIV SOUTHERN CALIFORNIA (US) | 2002-06-12 | — | — | EP | claimed |
| US-6287840-B1 | PEPTIDOMIMETICS; COUPLING, DEBLOCKING; ANTIARTHRITIC, ANTITUMOR, ANTICARCINOGENIC, AND ANTIMETASTASIS AGENTS; MUSCULAR DYSTROPHY, GLOMERULONEPHRITIS, MALARIA, ALZHEIMER*S DISEASE | AXYS PHARMACEUTICALS, INC. | 2001-09-11 | — | — | US | claimed |
| US-6281178-B1 | PREVENT FILMING AND/OR STREAKING AFTER A SURFACE IS CLEANED WITH THE COMPOSTIONS. | STEPAN COMPANY | 2001-08-28 | — | — | US | claimed |
| EP-1097160-A1 | PREPARATION AND USE OF ALPHA-KETO BISPHOSPHONATES | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2001-05-09 | — | — | EP | claimed |
| WO-2000002889-A1 | PREPARATION AND USE OF α-KETO BISPHOSPHONATES | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2000-01-20 | — | — | WO | claimed |
| WO-1998038202-A1 | ANTIVIRAL PHOSPHONATE PRODRUGS OF NUCLEOSIDES AND NUCLEOSIDE ANALOGUES | DANA-FARBER CANCER INSTITUTE (US) | 1998-09-03 | — | — | WO | claimed |
| EP-0003007-B1 | ALIPHATIC DERIVATIVES OF PHOSPHONOFORMIC ACID, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR COMBATING VIRUS INFECTIONS | Astra Läkemedel Aktiebolag (SE) | 1982-04-07 | — | — | EP | claimed |
| US-4240920-A | A SURFACTANT, A PEROXY BLEACH AND A PORPHINE BLEACH | THE PROCTER & GAMBLE COMPANY (US) | 1980-12-23 | — | — | US | claimed |
| EP-0003007-A2 | Aliphatic derivatives of phosphonoformic acid, pharmaceutical compositions and methods for combating virus infections | Astra Läkemedel Aktiebolag (SE) | 1979-07-11 | — | — | EP | claimed |
| EP-4735621-A1 | NUCLEIC ACID SYNTHESIS ON REUSABLE SUPPORT | DNA Script (FR) | 2026-05-06 | — | — | EP | disclosed |
| US-3932316-A | PHOSPHATE-FREE | THE PROCTER & GAMBLE COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040236135-A1 | Preparation and use of alpha-keto phosphonates | PNKP, PFKFB1, PDXK | MMP2 4817/4885MMP8 4522/4885MMP3 4832/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.